Skip to main content

Advertisement

SpringerLink
Log in

The prognosis and safety of continuous saline bladder irrigation in patients after transurethral resection of bladder tumors: a systematic review and meta-analysis of comparative study

  • Review Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

The prognosis and safety of continuous saline bladder irrigation (CSBI) after transurethral resection of bladder tumor (TURB) as an alternative method needs to be explored. A literature review and meta-analysis were performed by searching PubMed, EMBASE, Cochrane Library databases and original references of the included articles. PRISMA checklists were followed. We used the GRADEpro GDT to assess the certainty of evidence from the results of our meta-analysis. A total of eight articles including 1600 patients were studied. The results indicated that patients received CSBI after TURB had no statistical differences compared to the control group in the recurrence-free survival and progression-free survival. However, the CSBI group showed significant improvements compared to the control group in terms of the number of recurrences during follow-up and the period to first recurrence except for the number of tumor progression during follow-up. Furthermore, patients treated with CSBI did not show an inferior effect than those treated with immediate intravesical chemotherapy (IC) in respects of recurrence-free survival, progression-free survival, the number of recurrences during follow-up, the number of tumor progression during follow-up and the period to first recurrence. But the immediate IC group had a higher incidence than the CSBI group in terms of macrohematuria, micturition pain, frequency of urination, dysuria, retention and local toxicities. Patients treated with CSBI after TURB showed a significant improvement compared to the control group in terms of the number of recurrences during follow-up and the period to first recurrence. However, compared to immediate IC, CSBI did not show an inferior effect except for lower incidence of adverse reactions.

PROSPERO registration number CRD42021247088.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data sharing and data availability

All data can be obtained in the article.

References

  1. Flaig TW (2019) NCCN guidelines updates: management of muscle-invasive bladder cancer. J Natl Compr Cancer Netw JNCCN 17(55):591–593

    PubMed  CAS  Google Scholar 

  2. Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71(3):447–461

    Article  PubMed  Google Scholar 

  3. Witjes JA (2009) Topic issue on new treatments in bladder cancer. World J Urol 27(3):285–287

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Onishi T, Sasaki T, Hoshina A, Yabana T (2011) Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle invasive bladder tumor. Anticancer Res 31(4):1471–1474

    PubMed  Google Scholar 

  5. Brocks CP, Büttner H, Böhle A (2005) Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer. J Urol 174(3):1115–1118

    Article  PubMed  Google Scholar 

  6. Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R et al (2019) European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—2019 update. Eur Urol 76(5):639–657

    Article  PubMed  CAS  Google Scholar 

  7. Kang M, Jeong CW, Kwak C, Kim HH, Ku JH (2016) Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs. Oncotarget 7(29):45479–45488

    Article  PubMed  PubMed Central  Google Scholar 

  8. Murakami K, Hamada A, Teramoto Y, Matsumoto K, Kita Y, Saito R, Yamasaki T, Matsui Y, Inoue T, Ogawa O et al (2019) Efficacy of immediate postoperative instillation of chemotherapy for primary non-muscle-invasive bladder cancer in real-world clinical practice. Clin Genitourin Cancer 17(5):e1003–e1010

    Article  PubMed  Google Scholar 

  9. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg (Lond, Engl) 88:105906

    Article  Google Scholar 

  10. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E et al (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ (Clin Res Ed) 358:j4008

    Article  Google Scholar 

  11. Amir-Behghadami M, Janati A (2020) Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J EMJ 37(6):387

    Article  PubMed  Google Scholar 

  12. Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 10:Ed000142

  13. DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45(Pt A):139–145

    Article  PubMed  PubMed Central  Google Scholar 

  14. Gondran-Tellier B, Abdallah R, Sichez PC, Akiki A, Toledano H, Gaillet S, Delaporte V, Karsenty G, Bastide C, Daniel L et al (2021) Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer. Progres en urologie: journal de l’Association francaise d’urologie et de la Societe francaise d’urologie 31:316–323

    Article  PubMed  CAS  Google Scholar 

  15. Do J, Lee SW, Jeh SU, Hwa JS, Hyun JS, Choi SM (2018) Overnight continuous saline irrigation after transurethral resection for non-muscle-invasive bladder cancer is helpful in prevention of early recurrence. Canadian Urological Association journal = Journal de l’Association des urologues du Canada 12(11):E480-e483

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lenis AT, Asanad K, Blaibel M, Donin NM, Chamie K (2018) Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C. BMC Urol 18(1):93

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Onishi T, Sekito S, Shibahara T, Uchida K, Sasaki T (2018) The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer. Scand J Urol 52(5–6):385–388

    Article  PubMed  Google Scholar 

  18. Onishi T, Sugino Y, Shibahara T, Masui S, Yabana T, Sasaki T (2017) Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer. BJU Int 119(2):276–282

    Article  PubMed  CAS  Google Scholar 

  19. Yang Y, Liu C, Yan X, Li J, Yang X (2021) Overnight continuous saline bladder irrigation after En bloc resection of bladder tumor does not improve oncological outcomes in patients who have received intravesical chemotherapy. Front Oncol 11:638065

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Maekawa S, Suzuki H, Ohkubo K, Aoki Y, Okada T, Maeda H, Ogura K, Arai Y (2000) Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study. Hinyokika kiyo Acta urologica Japonica 46(5):301–306

    PubMed  CAS  Google Scholar 

  21. Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41(5):523–531

    Article  PubMed  Google Scholar 

  22. Böhle A (2004) A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. Int Braz J Urol 30(4):353–354

    Article  PubMed  Google Scholar 

  23. Iida K, Naiki T, Kawai N, Etani T, Ando R, Ikegami Y, Okamura T, Kubota H, Okada A, Kohri K et al (2016) Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer. BMC Urol 16:8

    Article  PubMed  PubMed Central  Google Scholar 

  24. Nieuwenhuijzen JA, Bex A, Horenblas S (2003) Unusual complication after immediate postoperative intravesical mitomycin C instillation. Eur Urol 43(6):711–712

    Article  PubMed  Google Scholar 

  25. Cliff AM, Romaniuk CS, Parr NJ (2000) Perivesical inflammation after early mitomycin C instillation. BJU Int 85(4):556–557

    Article  PubMed  CAS  Google Scholar 

  26. Floros N, Meletiadis K, Kusenack U, Zirngibl H, Kamper L, Haage P, Dreger NM (2015) Ruptured mycotic aortic aneurysm after Bacille Calmette-Guerin therapy. Ann Vasc Surg 29(7):1450.e1451-1454

    Article  Google Scholar 

  27. Rogoziński P, Taracha-Guz D, Pęcikiewicz P, Kachel T, Dubiel G, Wandzel P, Bruliński K (2014) Granulomatous pneumonia as a complication of intravesical BCG immunotherapy–a case report. Pneumonol Alergol Pol 82(2):163–169

    PubMed  Google Scholar 

  28. Singh NP, Prakash A, Kubba S, Ganguli A, Agarwal SK, Dinda AK, Aggarwal PN (2007) Nephrotic syndrome as a complication of intravesical BCG treatment of transitional cell carcinoma of urinary bladder. Ren Fail 29(2):227–229

    Article  PubMed  CAS  Google Scholar 

  29. Weldon TE, Soloway MS (1975) Susceptibility of urothelium to neoplastic cellular implantation. Urology 5(6):824–827

    Article  PubMed  CAS  Google Scholar 

  30. Nojiri Y, Okamura K, Kinukawa T, Ozawa H, Saito S, Okumura K, Terai A, Takei M (2007) Continuous bladder irrigation following transurethral resection of the prostate (TURP). Nihon Hinyokika Gakkai zasshi The japanese journal of urology 98(6):770–775

    PubMed  Google Scholar 

  31. Pawinski A, Sylvester R, Kurth KH, Bouffioux C, van der Meijden A, Parmar MK, Bijnens L (1996) A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. J Urol 156(6):1934–1940

  32. Lamm DL, Riggs DR, Traynelis CL, Nseyo UO (1995) Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder. J Urol 153(5):1444–1450

    Article  PubMed  CAS  Google Scholar 

  33. Sylvester RJ, Oosterlinck W, Witjes JA (2008) The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials. Eur Urol 53(4):709–719

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Williams SK, Hoenig DM, Ghavamian R, Soloway M (2010) Intravesical therapy for bladder cancer. Expert Opin Pharmacother 11(6):947–958

    Article  PubMed  CAS  Google Scholar 

  35. Solomon LZ, Birch BR, Cooper AJ (1998) Water as a tumoricidal agent in bladder cancer. In vitro studies in parental and resistant cell lines. Eur Urol 34(6):500–504

    Article  PubMed  CAS  Google Scholar 

  36. Bell MD (1992) Sudden death due to intravascular hemolysis after bladder irrigation with distilled water. J Forensic Sci 37(5):1401–1406

    Article  PubMed  CAS  Google Scholar 

  37. Dorotta I, Basali A, Ritchey M, O’Hara JF Jr, Sprung J (2003) Transurethral resection syndrome after bladder perforation. Anesth Analg 97(5):1536–1538

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors have no acknowledgments to declare.

Author information

Author notes

  1. Xiang Wang and Yan Wang: co-first authors.

Authors and Affiliations

  1. Department of Urology, Tengzhou Central People’s Hospital, Tengzhou, 277500, China

    Xiang Wang & Bo Cheng

  2. Department of Urology, Beijing Tian Tan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing, 100070, China

    Xuanyan Che & Zhongbao Zhou

  3. Department of Traditional Chinese Medicine, The Sixth Medical Center of PLA General Hospital, Beijing, China

    Yan Wang

Authors
  1. Xiang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xuanyan Che
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhongbao Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bo Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ZZ: data curation; investigation; formal analysis; writing—original draft. XW: data curation; investigation; methodology; resources; supervision; visualization; writing—original draft. YW: formal analysis; investigation; methodology; validation; visualization; writing—review and editing. XC: formal analysis; investigation; methodology; validation; visualization; writing—review and editing. BC: conceptualization; funding acquisition; methodology; project administration; writing—review and editing.

Corresponding authors

Correspondence to Zhongbao Zhou or Bo Cheng.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Compliance with Ethical Standards, Research involving human participants and/or animals

Not Applicable.

Informed consent

Not Applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 31 KB)

Supplementary file2 (PDF 2111 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Wang, Y., Che, X. et al. The prognosis and safety of continuous saline bladder irrigation in patients after transurethral resection of bladder tumors: a systematic review and meta-analysis of comparative study. Updates Surg 75, 1795–1806 (2023). https://doi.org/10.1007/s13304-023-01525-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-023-01525-4

Keywords

Search

Navigation